As the autism population ages, the incidence of seizures is increasingly reported.
Unfortunately, there is very little in the way of consensus as to causes or treatments. We know seizures present a danger. Elias Tembenis, who was recovering from autism, ultimately passed away while having a seizure. Autism One brings together leading experts to compare notes and research agendas, grow ideas, and find common ground that will provide paths and answers for parents on what treatments are best given each child’s unique biomedical background. Presentations and Q&A panel discussion for all conference attendees will follow on Sunday.
Among the participants at the think tank:
Rob Coben, PhD is the director and chief neuropsychologist of a private clinic in NY, which is also an affiliated research site with NYU's Brain Research Lab. Dr. Coben is board certified in EEG biofeedback and a diplomat of the QEEG Certification Board.
S. Hossein Fatemi, MD, PhD is a professor of psychiatry, adjunct professor of neuroscience, and adjunct professor of pharmacology. Dr. Fatemi authored GABAA Receptor Downregulation in Brains of Subjects with Autism and Expression of GABAB Receptors Is Altered in Brains of Subjects with Autism.
Richard Frye, MD, PhD is an assistant professor, Department of Pediatrics, Division of Neurology, University of Texas-Houston Medical School. Dr. Frye completed his residency in pediatrics at the University of Miami, Jackson Memorial Hospital, and his residency in neurology at Children's Hospital Boston.
Paul Hardy, MD is a board certified neurologist with subspecialty training in behavioral neurology/neuropsychiatry. He has held teaching appointments at Harvard Medical School and Tufts University School of Medicine. A particular interest for him has been the recognition, evaluation, and treatment of developmentally disabled individuals with occult subclinical seizures.
Jeffrey Lewine, PhD is the executive director of the Alexian Brothers Center for Brain Research and the Illinois Magnetoencephalography Center. He received his doctorate in neuroscience from the University of Rochester where he was a member of the Center for Brain Research and the Center for Visual Science. At Los Alamos National Laboratory, he worked on the development of magnetoencephalography [MEG], then a new method for studying brain function.
Derrick MacFabe, MD is an assistant professor and director of the Kilee Patchell-Evans Autism Research Group, Departments of Psychology (Neuroscience) and Psychiatry (Division of Developmental Disabilities) at the Schulich School of Medicine and Dentistry, University of Western Ontario.
Jon Poling, MD, PhD is the medical director of the Athens Regional Medical Center Apheresis Unit, clinical assistant professor at the Medical College of Georgia, and a partner at Athens Neurological Associates. He is certified in MRI/CT interpretation by the American Society of Neuroimaging, is a diplomate of the American Association of Neuromuscular and Electrodiagnostic Medicine, and is board certified by the American Board of Psychiatry and Neurology.
Harry Schneider, MD is an associate research scientist, Functional MRI Research Center of Columbia University. He is in private practice at the Center for Medical and Brain Sciences in Plainview, NY.
Allan Sosin, MD is the founder and medical director of the Institute for Progressive Medicine. Dr. Sosin held the position of assistant medical director at The Institutes for the Achievement of Human Potential, a world-renowned facility for the treatment of brain injured children.
For extended bios and a complete listing of practitioners, please visit HERE..
Autism One thanks Prof. James Adams for moderating this event.
SUNDAY PRESENTATION SCHEDULE ON THIS TOPIC:
8:00 - 10:00 Dr. Paul Hardy; Dr. S.H. Fatemi; Dr. Allan Sosin
10:30-12:30 Dr. Richard Frye; Dr. Tappan Audhya; Dr. Derrick MacFabe
1:15 - 2:15 Dr. Rob Coben; Dr. Jeffrey Lewine
2:15 - 3:00 Panel Q & A
For a complete main conference schedule, please visit http://www.autismone.org/schedules.
The Treatment category is sponsored by Lee Silsby, the leader in quality compounded medications for autism.